Keyphrases
Immune Response
100%
Pancreatic Ductal Adenocarcinoma
100%
Overall Survival
100%
Prolonged Survival
100%
T Helper 1
100%
Metastatic Lymph Node
100%
CD8+
55%
Positive Lymph Nodes
44%
Clinical Outcomes
22%
T-bet
22%
Th1 Immune Response
22%
Transcription Factor
11%
Heterogeneous Groups
11%
High-grade Tumor
11%
Improved Survival
11%
Primary Tumor
11%
Graves
11%
Lymph Node Metastasis
11%
Morphological Parameters
11%
Worse Outcome
11%
Well-differentiated
11%
Tumor Size
11%
Immune Parameters
11%
Histopathological Features
11%
Biological Markers
11%
Poor Differentiation
11%
Effector Cells
11%
Immunohistochemical Features
11%
Perineural Invasion
11%
Moderately Differentiated
11%
T Stage
11%
Lymph Node Ratio
11%
Prognostic Sign
11%
Medicine and Dentistry
Pancreas Adenocarcinoma
100%
Immune Response
100%
Overall Survival
100%
Lymph Node Metastasis
100%
Lymph Node
55%
CD8 Antigen
55%
Neoplasm
22%
Biological Marker
11%
Morphology
11%
Primary Tumor
11%
Immunotherapy
11%
Perineural Invasion
11%
Effector Cell
11%
Transcription Factor T Bet
11%
Pharmacology, Toxicology and Pharmaceutical Science
Overall Survival
100%
Lymph Node Metastasis
100%
Pancreas Adenocarcinoma
100%
CD8 Antigen
55%
Neoplasm
22%
Biological Marker
11%
Primary Tumor
11%
Immunotherapy
11%
Perineural Invasion
11%
Transcription Factor T Bet
11%
Immunology and Microbiology
Immune Response
100%
Lymph Node
100%
Overall Survival
100%
CD8
55%
Morphology
11%
Immunotherapy
11%
Tumor Volume
11%
Effector Cell
11%
TBX21
11%